Response should come from jointly from MD Anderson and NWBO
This definitely should not be a press release from NWBO solely. It either should come from MD Anderson as someone else just pointed out, or a joint release, which is the strongest IMHO. My preliminary draft: "Recently a reporter quoted a doctor who practices in the oncology department of MD Anderson, regarding a phase1/2 cancer trial being conducted at two MD Anderson sites on behalf of Northwest Biotherapeutics. The quotes, which were taken out of context, suggested that the data disseminated by Northwest Bio thus far may be misleading, or that disseminating the data itself is inappropriate for the protocols of the trial. As the supervising physician at MD Anderson overseeing these trials and the primary contact with Northwest Bio in sharing data as it becomes available, I can say without reservation that all data presented to the public to date has been accurate and in accordance with an unblinded, open label study that is primarily observational by design. MD Anderson will provide a complete set of data to NW Bio at the conclusion of this trial, which at the time will be framed within traditional efficacy measurements."